Search Results 411-420 of 21235 for anti-TNF drugs

  1. Ustekinumab-Auub (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Wezlana. Descriptions. Ustekinumab-auub injection is used ...

  2. Naproxen (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  3. Rho(D) Immune Globulin (Injection Route, Intramuscular Route, Intravenous Route) Description and Brand Names - Mayo Clinic

    It belongs to a group of medicines called immunizing agents. Rho(D) immune globulin works to boost the immune system and prevent excessive bleeding.

  4. Anakinra (Subcutaneous Route) Proper Use - Mayo Clinic

    Proper Use. Drug information provided by: Merative, Micromedex®. COVID-19: A doctor or other trained health professional will give you this medicine ...

  5. Domperidone (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Aminophylline (Oral Route) Before Using - Mayo Clinic

    Adalimumab; Adenosine; Amifampridine; Bupropion ... drugs may be the best treatment for you. If both ... Certain medicines should not be used at or ...

  7. Fenofibrate (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Antara; Fenoglide; Lipofen; Lofibra; Tricor; Triglide ...

  8. Triamcinolone (Injection Route) Description and Brand Names - Mayo Clinic

    It is given to patients who are not able to take medicines by the mouth. This medicine is a corticosteroid (cortisone-like medicine or steroid).

  9. Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma · Overview · Participation ...

  10. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... [anti-TNF] agents) within 2 weeks prior to randomization. Patients who have ...